Pharma channel feed

Eli Lil­ly set­tles with med­ical spa over its mar­ket­ing of com­pound­ed tirzepatide

Last year
Law

WHO green­lights Takeda's dengue vac­cine as com­pa­ny plans to 're-en­gage' with FDA

Last year
FDA+

House com­mit­tee ad­vances bi­par­ti­san bill tar­get­ing Chi­nese biotech sup­pli­ers

Last year

As ad­comm looms, ICER rais­es ques­tions over Lykos’ MD­MA stud­ies

Last year
FDA+

GoodRx gets back in Kroger's good graces, will work di­rect­ly with gro­cer

Last year
Health Tech

Ei­sai projects near-term Leqem­bi sales 'con­sid­er­ably high­er' than an­a­lyst fore­casts

Last year

Ei­sai heads to FDA with sub­cu­ta­neous ver­sion of Alzheimer’s treat­ment de­vel­oped with Bio­gen

Last year
FDA+

As­cendis’ hy­poparathy­roidism drug sad­dled with three-month de­lay at FDA

Last year
FDA+

De­struc­tion of doc­u­ments, in­suf­fi­cient da­ta lead FDA to re­ject hep B vac­cine up­date

Last year
FDA+

Bay­er cuts 1,500 staffers com­pa­ny­wide in cam­paign to re­duce bu­reau­cra­cy

Last year
R&D

Pfiz­er sub­mits trade­mark ap­pli­ca­tion that sug­gests it could be launch­ing a di­rect-to-pa­tient pro­gram

Last year
Health Tech

Ab­b­Vie goes deep­er in­to neu­ro­science with col­lab­o­ra­tion worth as much as $2B

Last year
Deals

WHO mem­bers miss dead­line for pan­dem­ic ac­cord draft, will con­tin­ue talks

Last year
FDA+

Size of 340B mar­ket triples since 2018 and may dou­ble again, re­port says

Last year

Cy­to­ki­net­ics lifts cur­tain on Phase 3 afi­camten da­ta, com­mer­cial launch prep un­der­way

Last year
R&D

Take­da bets $100M up­front on AC Im­mune's an­ti-amy­loid Alzheimer's vac­cine

Last year
Deals

Sanofi buys ex-US rights to Ful­crum's Phase 3 rare neu­ro­mus­cu­lar drug

Last year
Deals

New Biose­cure draft fea­tures 2032 grand­fa­ther clause, five-year grace pe­ri­od for added com­pa­nies

Last year
China
FDA+

Sen­a­tors ques­tion Cham­ber of Com­merce's mo­tives around march-in rights

Last year
FDA+

House Re­pub­li­cans put pres­sure on AS­PR’s man­age­ment of the na­tion­al drug stock­pile

Last year
Law

FDA de­lays Mod­er­na RSV vac­cine de­ci­sion, but what's next is like­ly to be a tougher, longer climb

Last year

Sanofi grabs a share of No­vavax's Covid vac­cine for $500M, eye­ing com­mer­cial­iza­tion, flu com­bi­na­tion

Last year
Deals
Coronavirus

Af­ter FTC scruti­ny of Sanofi deal, Maze finds a new Pompe part­ner in Sh­iono­gi

Last year
Deals
R&D

Take­da to shut down San Diego re­search cen­ter 

Last year
People
First page Previous page 53545556575859 Next page Last page
A service from the Financial Times